INvestigation of STEnt grafts in patients with type B Aortic Dissection: Design of the INSTEAD trial-a prospective, multicenter, European randomized trial

The INSTEAD trial is the first randomized trial investigating the role of endoluminal treatment of uncomplicated type B aortic dissection. By the end of December 2004, 125 patients were randomized, accounting for 92% of the target. Final results of the INSTEAD trial should be available in 2006.